Photodynamic therapy of penile leukoplakia: a case report
https://doi.org/10.37895/2071-8004-2021-25-3-29-33
Abstract
Purpose: to describe a clinical case of successful application of photodynamic therapy (PDT) in a patient with leukoplakia of the glans penis skin.
Material and methods. For PDT, chlorin-type photosensitizer “Photolon” was used. The photosensitizer (lyophilized powder) was diluted in 200.0 ml of 0.9 % sodium chloride solution, administered intravenously at dosage 1.5 mg/kg of body weight. After 2.5 hours, intravenous laser blood irradiation was performed with “Lakhta-Milon” laser device (output power – 100 mW, exposure – 30 minutes). Before PDT, fluorescence diagnostics in ultraviolet light with wavelength 395–405 nm was performed. PDT technique was single-field irradiation with output power 1800 mW (1.8 W), irradiation energy density – 150 J/cm2. Power density of laser light was 200 mW/cm2. Exposure time – 14 min.
Results. After treatment, complete regression of the pathological focus and regeneration of healthy tissue were marked (one month).
Conclusion. PDT in a patient with leukoplakia of glans penis is an effective and safe curative technique.
About the Authors
N. A. ShanazarovKazakhstan
Shanazarov Nasrulla – Dr. Sc. (Med.), Professor, Oncologist, Deputy Director.
Nur-Sultan
B. G. Kassymov
Kazakhstan
Kassymov Bakhtiyar – Urologist.
Nur-Sultan
T. M. Muratov
Kazakhstan
Muratov Timur – Urologist.
Nur-Sultan
S. V. Zinchenko
Russian Federation
Zinchenko Sergey – Dr. Sc. (Med.), Docent, Oncologist, Republican Clinical Oncological Dispensary; Head of the Department of Surgery, Obstetrics and Gynecology, KFU.
Kazan
References
1. Yagudaev D.M., Purtskhvanidze V.A. Method of photodynamic therapy of superfi cial cancer and precancerous diseases of the penis: Patent N 2611952 of the Russian Federation. 2017; 7. [In Russ.]
2. Pushkar D.Yu. Urology: textbook for students of institutions of higher professional education. Moscow: GEOTAR-Media; 2013: 384 p. [In Russ.]
3. Trushin A.A., Golovashchenko M.P., Filonenko E.V. Fluorescent diagnostics of non-muscle invasive bladder cancer. P.A. Herzen Journal of Oncology. 2018; 7 (6): 74–79. [In Russ.]
4. Sukonko O.G. Guide to oncology. Minsk: Entsykl. im. P. Brovki; 2016: 440. [In Russ.]
5. Filonenko E.V., Serova L.G. Photodynamic therapy in clinical practice. Biomedical Photonics. 2016; 5 (2): 26–37. [In Russ.]
6. Taranets T.A., Sukhova T.E., Romanko Yu.S. Photodynamic therapy of basal cell skin cancer with local and intravenous use of the chlorin series photosensitizer “Photolon”. Almanac of Clinical Medicine. 2007; 15: 283–288. [In Russ.]
7. Sedova T.G., Khlebnikova A.N. Clinical and morphological features of the leukoplakia in the Perm region. Almanac of Clinical Medicine. 2018; 46 (4): 347–354. [In Russ.]. DOI: 10.18786/2072-0505-2018-46-4-347-354
8. Tserkovsky D.A., Artemieva T.P. Photodynamic therapy of glans leukoplakia (clinical observation). Biomedical Photonics. 2018; 7 (1): 37–40. [In Russ.]. DOI: 10.24931/24139432-2018-7-1-37-40
9. Bilyalov A.I., Shanazarov N.A., Zinchenko S.V. Photodynamic therapy as alternative method of treatment of metastatic ovarian cancer with many recurrences: Case report. BioNanoSci. 2020; 10: 807–810. DOI: 10.1007/s12668-020-00749-7
Review
For citations:
Shanazarov N.A., Kassymov B.G., Muratov T.M., Zinchenko S.V. Photodynamic therapy of penile leukoplakia: a case report. Laser Medicine. 2021;25(3):29-33. (In Russ.) https://doi.org/10.37895/2071-8004-2021-25-3-29-33